US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bristol-Myers Squibb

48.76

-1.0600-2.13%

Volume:1.45M

Turnover:70.29M

Market Cap:99.22B

PE:-11.05

High:49.12

Open:47.63

Low:47.61

Close:49.82

Loading ...

Overview Company News Filings

Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy for Long Term Growth?

Bristol-Myers Squibb, Optellum Collaborate to Boost Early Lung Cancer Diagnosis

MT Newswires Live

BRIEF-Optellum Announces Agreement With Bristol Myers Squibb To Leverage Ai To Boost Early Lung Cancer Diagnosis

BUZZ-Cytokinetics falls after rival Bristol Myers' heart drug fails trial

Optellum Announces Agreement With Bristol Myers Squibb to Leverage AI to Boost Early Lung Cancer Diagnosis

THOMSON REUTERS

Bristol-Myers Squibb Company (BMY): Among the Best Value Dividend Stocks to Buy According to Billionaires?

BRIEF-Bristol Myers Squibb Provides Update On Phase 3 ODYSSEY-HCM Trial

BUZZ-Bristol Myers falls as heart disease drug fails in late-stage trial

Bristol-Myers' Camzyos Phase 3 Trial Misses Dual Primary Endpoints

MT Newswires Live

CORRECTED-UPDATE 2-Bristol Myers' heart disease drug fails to meet main goals in late-stage study (April 14)

Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Bristol Myers says Phase 3 ODYSSEY-HCM Camzyos trial did not meet endpoints

Bristol-Myers Squibb Co - No New Safety Signals Observed in Odyssey-HCM Trial

THOMSON REUTERS

Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial

Nu, HPE, Merck, BMY, OXY: Trending by Analysts

Bristol-Myers Squibb Gets FDA Approval for Opdivo-Yervoy Combo in Liver Cancer Treatment

MT Newswires Live

FDA Approves Bristol Myers Squibb's Opdivo Plus Yervoy to Treat Some Carcinomas

Bristol Myers says FDA approves Opdivo plus Yervoy as first-line HCC treatment

Bristol-Myers Squibb Investors Likely to Focus on Performance of New Schizophrenia Therapy, UBS Says

MT Newswires Live

Pharma Tariffs Are Coming. Investors Underestimate the Risk. -- Barrons.com

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BMY/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMY\",,,,,undefined,":{"symbol":"BMY","market":"US","secType":"STK","nameCN":"Bristol-Myers Squibb","latestPrice":48.76,"timestamp":1745415210774,"preClose":49.82,"halted":0,"volume":1446558,"delay":0,"floatShares":2030829795,"shares":2034763196,"eps":-4.414405,"marketStatus":"Trading","change":-1.06,"latestTime":"04-23 09:33:31 EDT","open":47.63,"high":49.12,"low":47.61,"amount":70292997.93024,"amplitude":0.030309,"askPrice":48.78,"askSize":800,"bidPrice":48.74,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-4.414405,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745438400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":-18475200000,"exchange":"NYSE","adjPreClose":49.82,"dividendRate":0.049631,"preHourTrading":{"tag":"盘前","latestPrice":47.87,"preClose":49.82,"latestTime":"09:29 EDT","volume":289474,"amount":13746248.364311999,"timestamp":1745414999981},"postHourTrading":{"tag":"盘后","latestPrice":47.75,"preClose":49.82,"latestTime":"19:59 EDT","volume":3023094,"amount":147008694.492399,"timestamp":1745366371032},"volumeRatio":10.274651,"impliedVol":0.3907,"impliedVolPercentile":0.908},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMY\",,,,,undefined,":{"symbol":"BMY","floatShares":2030829795,"roa":"6.55%","roe":"-38.95%","lyrEps":-4.414405,"volumeRatio":10.274651,"shares":2034763196,"dividePrice":2.42,"high":49.12,"amplitude":0.030309,"preClose":49.82,"low":47.61,"week52Low":39.35,"pbRate":"6.07","psRate":"2.05","week52High":63.33,"institutionHeld":0.6798,"latestPrice":48.76,"committee":-0.454545,"eps":-4.414405,"divideRate":0.049631,"volume":1446558,"delay":0,"ttmEps":-4.414405,"open":47.63,"prevYearClose":56.56,"prevWeekClose":49.23,"prevMonthClose":60.99,"prevQuarterClose":60.99,"fiveDayClose":50,"twentyDayClose":59.19,"sixtyDayClose":60.6,"earningDate":1745424000000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMY\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527426566","title":"Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy for Long Term Growth?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527426566","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527426566?lang=en_us&edition=fundamental","pubTime":"2025-04-16 01:38","pubTimestamp":1744738726,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a look at where Bristol-Myers Squibb Company  stands against other best pharma stocks to buy for long term growth.With big American pharmaceutical corporations always searching for medications in China, the US pharmaceutical industry is going through a unique trend never seen before. About 30% of Big Pharma acquisitions involving at least $50 million upfront in 2024 involved Chinese corporations, according to DealForma statistics, as reported by CNBC. This was an increase from 20% the previous year and nearly 0% just five years before.Speaking about the tariffs, she stated that since some businesses assemble their products in the US after producing them overseas, their implementation raises several unanswered questions for the pharmaceutical industry. These businesses, therefore, have relatively low manufacturing costs, which is an important factor to take into accou","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bristol-myers-squibb-company-bmy-173846451.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0061475181.USD","IE00BJJMRZ35.SGD","LU1868836591.USD","BK4581","IE0002141913.USD","LU2125154935.USD","LU2242646821.SGD","LU1093756325.SGD","IE00B2B36J28.USD","BK4007","LU1261432733.SGD","BK4585","LU1670710588.SGD","LU0868494617.USD","LU1670711040.USD","LU1585245621.USD","LU1718418525.SGD","LU1868837300.USD","IE0009355771.USD","LU1571399168.USD","LU0237698245.USD","LU2133065610.SGD","LU0321505439.SGD","LU1093756168.USD","BK4534","BK4532","LU0882574055.USD","LU1989771016.USD","LU1868837136.USD","IE00BJT1NW94.SGD","LU0456855351.SGD","LU1323610961.USD","LU1868836757.USD","LU1032466523.USD","LU2125154778.USD","BMY","LU0321505868.SGD","LU0985481810.HKD","LU1670711123.USD","LU1074936037.SGD","LU0306806265.USD","LU0225771236.USD","LU1670710661.SGD","LU0306807586.USD","BK4559","LU1868836914.USD","LU0114720955.EUR","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","LU0096364046.USD"],"gpt_icon":1},{"id":"2527408449","title":"Bristol-Myers Squibb, Optellum Collaborate to Boost Early Lung Cancer Diagnosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2527408449","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527408449?lang=en_us&edition=fundamental","pubTime":"2025-04-15 23:07","pubTimestamp":1744729635,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb  and lung health company Optellum are collaborating to boost early lung cancer diagnosis using artificial intelligence, Optellum said Tuesday.Under the companies' agreement, Optellum will use its Virtual Nodule Clinic platform at various US health care systems to democratize access to early diagnosis and to evaluate the platform's real-world impact before and after implementation, Optellum said.The company said the deployments of the platform aim to generate and promote evidence and AI implementation best practices, helping accelerate AI-powered early diagnosis.Price: 50.30, Change: -1.04, Percent Change: -2.03","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0321505868.SGD","BMY","LU1670711040.USD","BK4581","LU0225771236.USD","LU1989771016.USD","LU0114720955.EUR","LU1868837300.USD","LU2133065610.SGD","LU0225284248.USD","LU0237698245.USD","BK4559","LU1032466523.USD","LU1868836757.USD","LU0321505439.SGD","BK4532","LU0306807586.USD","LU1670711123.USD","IE00B2B36J28.USD","LU1430594728.SGD","LU2125154935.USD","LU0456855351.SGD","LU1093756325.SGD","BK4585","LU1670710588.SGD","IE0002141913.USD","LU1093756168.USD","LU0985481810.HKD","LU1670710661.SGD","IE00BSNM7G36.USD","LU1718418525.SGD","LU2242652126.USD","LU0882574055.USD","BK4534","LU1571399168.USD","LU0061475181.USD","LU0868494617.USD","IE00BFXG1179.USD","LU2242646821.SGD","LU0306806265.USD","IE00BJJMRZ35.SGD","LU2125154778.USD","BK4007","LU1868837136.USD","LU0096364046.USD","IE0009355771.USD","LU1585245621.USD","IE00BFTCPJ56.SGD","LU1323610961.USD","LU1261432733.SGD"],"gpt_icon":0},{"id":"2527414786","title":"BRIEF-Optellum Announces Agreement With Bristol Myers Squibb To Leverage Ai To Boost Early Lung Cancer Diagnosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2527414786","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527414786?lang=en_us&edition=fundamental","pubTime":"2025-04-15 21:28","pubTimestamp":1744723703,"startTime":"0","endTime":"0","summary":"BRIEF-Optellum Announces Agreement With Bristol Myers Squibb To Leverage Ai To Boost Early Lung Cancer DiagnosisApril 15 (Reuters) - Bristol-Myers Squibb Co BMY.N:OPTELLUM ANNOUNCES AGREEMENT WITH BRI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QT0YP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505868.SGD","LU2360032135.SGD","LU0306807586.USD","IE0009355771.USD","LU2242652126.USD","LU1093756325.SGD","BK4532","LU1718418525.SGD","LU1868837136.USD","BK4585","LU2133065610.SGD","LU2125154935.USD","IE0002141913.USD","LU1291159041.SGD","LU1670710588.SGD","LU1571399168.USD","LU2242646821.SGD","LU1670711123.USD","LU1032466523.USD","LU0225771236.USD","LU0225284248.USD","LU1261432733.SGD","IE00BSNM7G36.USD","LU0882574055.USD","LU2125154778.USD","LU1868836914.USD","BK4559","LU0061475181.USD","LU1430594728.SGD","BK4588","LU1868837300.USD","LU1670711040.USD","LU1868836591.USD","LU1093756168.USD","LU1868836757.USD","LU1585245621.USD","LU0096364046.USD","LU0306806265.USD","IE00BFTCPJ56.SGD","BK4534","LU1670710661.SGD","LU0868494617.USD","LU0456855351.SGD","LU1074936037.SGD","BMY","BK4581","BK4007","LU0237698245.USD","LU0321505439.SGD","LU1989771016.USD"],"gpt_icon":0},{"id":"2527196414","title":"BUZZ-Cytokinetics falls after rival Bristol Myers' heart drug fails trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2527196414","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527196414?lang=en_us&edition=fundamental","pubTime":"2025-04-15 21:00","pubTimestamp":1744722039,"startTime":"0","endTime":"0","summary":"BUZZ-Cytokinetics falls after rival Bristol Myers' heart drug fails trial** Shares of drug developer Cytokinetics CYTK.O fall 3.7% to $38.35 premarket** Rival Bristol Myers Squibb BMY.N said late on Monday its drug, mavacamten, to treat a type of heart disease did not significantly improve functional capacity and symptoms in patients, failing to meet the main goals of a late-stage study** CYTK is also developing an experimental heart drug, aficamten, to treat non-obstructive form of hypertrophic cardiomyopathy, an inherited condition characterized by thickening of heart muscles** BofA says most of its prescribers see the two drugs as \"more similar than not clinically\"** Brokerage suggests that there might be more discussions about the importance of this class of drugs for all patients, not just those with severe symptoms, due to ongoing uncertainties about the overall potential** Up to last close, CYTK shares down 15.4% ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nL4N3QT13O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225771236.USD","LU0321505868.SGD","LU0096364046.USD","LU1093756168.USD","LU1868836914.USD","IE00BFXG1179.USD","BK4581","LU1261432733.SGD","LU2242652126.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU1074936037.SGD","LU1032466523.USD","LU0306806265.USD","BK4139","IE0002141913.USD","BMY","LU1291159041.SGD","LU1868837136.USD","LU2242646821.SGD","LU1670711040.USD","BK4559","LU0868494617.USD","LU0882574055.USD","LU0061475181.USD","BK4505","LU1670711123.USD","BK4534","LU1430594728.SGD","LU1718418525.SGD","LU1989771016.USD","LU2125154935.USD","LU0237698245.USD","LU0456855351.SGD","LU0321505439.SGD","BK4585","CYTK","IE0009355771.USD","LU1868837300.USD","BK4007","LU1323610961.USD","LU2133065610.SGD","LU2125154778.USD","BK4532","BK4588","LU0306807586.USD","IE00BSNM7G36.USD","LU2360032135.SGD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2527949025","title":"Optellum Announces Agreement With Bristol Myers Squibb to Leverage AI to Boost Early Lung Cancer Diagnosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2527949025","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527949025?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:02","pubTimestamp":1744718567,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QT0YP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0237698245.USD","LU1670710588.SGD","LU1074936037.SGD","LU1718418525.SGD","LU0985481810.HKD","LU1868837300.USD","LU1585245621.USD","LU0321505439.SGD","BK4559","IE00BSNM7G36.USD","LU0225284248.USD","LU0321505868.SGD","LU0882574055.USD","BK4581","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU1093756168.USD","LU1093756325.SGD","LU1670710661.SGD","LU1868836591.USD","LU1868836757.USD","LU1868837136.USD","LU2133065610.SGD","BK4534","LU1670711040.USD","LU0061475181.USD","LU0868494617.USD","LU1571399168.USD","IE00BJT1NW94.SGD","LU2125154778.USD","LU1868836914.USD","IE00BFTCPJ56.SGD","BK4585","LU1430594728.SGD","LU0306807586.USD","BK4532","LU1291159041.SGD","LU2242646821.SGD","IE0009355771.USD","LU2125154935.USD","LU2360032135.SGD","IE00BFXG1179.USD","LU0096364046.USD","LU1323610961.USD","LU1261432733.SGD","LU0225771236.USD","BK4007","BK4588","LU0114720955.EUR","BMY"],"gpt_icon":0},{"id":"2527490232","title":"Bristol-Myers Squibb Company (BMY): Among the Best Value Dividend Stocks to Buy According to Billionaires?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527490232","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527490232?lang=en_us&edition=fundamental","pubTime":"2025-04-15 19:35","pubTimestamp":1744716915,"startTime":"0","endTime":"0","summary":"We recently published a list of the10 Best Value Dividend Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Bristol-Myers Squibb Company  stands against other best value dividend stocks.Dividends, though sometimes underappreciated, have significantly contributed to long-term investor gains. Between 1960 and the end of the previous year, reinvested dividends and the effects of compounding accounted for about 85% of the S&P Index’s total return. Dividend-oriented strategies offer the advantage of steady income, improved portfolio stability, and a potential buffer during uncertain economic periods—making them a strong choice for all-weather portfolios.Historically, income-focused investing often leans heavily toward value stocks, as investors typically look for companies offering high dividend yields and lower valuation multiples. However, a report by S&P Dow Jones Indices points out that the Dividend Aristocrats Index strikes a balance between","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bristol-myers-squibb-company-bmy-113515189.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","LU1032466523.USD","IE00BJJMRZ35.SGD","LU0237698245.USD","BK4585","LU2242646821.SGD","IE0009355771.USD","LU2125154778.USD","LU1868836591.USD","LU1093756168.USD","LU0096364046.USD","LU0882574055.USD","LU1074936037.SGD","LU1670710661.SGD","LU0985481810.HKD","LU1323610961.USD","LU1868836914.USD","IE00BJT1NW94.SGD","LU0456855351.SGD","LU1093756325.SGD","LU1670710588.SGD","BK4559","LU1868837136.USD","BK4532","LU1291159041.SGD","IE00B2B36J28.USD","LU1571399168.USD","LU1670711040.USD","BK4534","LU2242652126.USD","LU1585245621.USD","LU0225771236.USD","LU0114720955.EUR","LU1868836757.USD","LU1261432733.SGD","BMY","LU2125154935.USD","BK4581","LU0225284248.USD","IE00BSNM7G36.USD","LU1430594728.SGD","LU0306807586.USD","LU0321505868.SGD","BK4007","LU0321505439.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU2133065610.SGD","LU0061475181.USD","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2527128329","title":"BRIEF-Bristol Myers Squibb Provides Update On Phase 3 ODYSSEY-HCM Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2527128329","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527128329?lang=en_us&edition=fundamental","pubTime":"2025-04-15 05:46","pubTimestamp":1744667167,"startTime":"0","endTime":"0","summary":"BRIEF-Bristol Myers Squibb Provides Update On Phase 3 ODYSSEY-HCM TrialApril 14 (Reuters) - Bristol-Myers Squibb Co BMY.N:BRISTOL MYERS SQUIBB PROVIDES UPDATE ON PHASE 3 ODYSSEY-HCM TRIALBRISTOL-MYERS","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nTUA2ZKXFC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4534","LU0096364046.USD","LU1291159041.SGD","LU1093756325.SGD","IE00BSNM7G36.USD","LU0225771236.USD","LU1032466523.USD","LU1670710588.SGD","LU0114720955.EUR","LU0237698245.USD","LU0061475181.USD","LU0985481810.HKD","LU0321505439.SGD","LU0321505868.SGD","LU2242646821.SGD","LU2242652126.USD","BK4581","IE00BJJMRZ35.SGD","LU1585245621.USD","LU1868837300.USD","BK4007","BMY","LU0225284248.USD","LU1571399168.USD","LU1430594728.SGD","BK4559","IE00BJT1NW94.SGD","LU1670711123.USD","IE00BFXG1179.USD","LU0882574055.USD","LU1989771016.USD","LU1074936037.SGD","LU1868836591.USD","LU1868836757.USD","IE0002141913.USD","LU1718418525.SGD","LU2125154935.USD","LU2360032135.SGD","LU1670710661.SGD","IE00BFTCPJ56.SGD","LU0306807586.USD","IE0009355771.USD","LU0306806265.USD","LU2125154778.USD","IE00B2B36J28.USD","LU0868494617.USD","LU0456855351.SGD","LU1323610961.USD","BK4588"],"gpt_icon":0},{"id":"2527147847","title":"BUZZ-Bristol Myers falls as heart disease drug fails in late-stage trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2527147847","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527147847?lang=en_us&edition=fundamental","pubTime":"2025-04-15 05:13","pubTimestamp":1744665221,"startTime":"0","endTime":"0","summary":"BUZZ-Bristol Myers falls as heart disease drug fails in late-stage trial** Shares of drugmaker Bristol Myers Squibb BMY.N fall 1.6% to $50.50 in extended trading** Co says its experimental heart disease drug, mavacamten, did not meet the main goals in a late-stage study** The drug was being tested to treat adult patients with with the so-called non-obstructive form of hypertrophic cardiomyopathy , an inherited condition characterized by thickening of heart muscles** The drug, branded as Camzyos, did not improve symptoms or exercise more easily in patients with nHCM** The drug is already approved in the U.S. for the obstructive form of the disease** As of last close, stock down 9.2% YTD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nL4N3QS1L9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868837136.USD","LU0225771236.USD","LU0321505439.SGD","IE00BSNM7G36.USD","BK4581","BK4007","IE00BJJMRZ35.SGD","BK4559","LU1868837300.USD","LU1718418525.SGD","LU0114720955.EUR","LU2360032135.SGD","LU0237698245.USD","LU2242652126.USD","LU2133065610.SGD","LU2125154935.USD","LU1074936037.SGD","LU0306807586.USD","LU1670710661.SGD","LU1868836757.USD","BK4534","IE00B2B36J28.USD","BK4588","LU1670711123.USD","LU1261432733.SGD","BMY","IE00BFTCPJ56.SGD","BK4585","LU0061475181.USD","LU0306806265.USD","LU1989771016.USD","IE00BJT1NW94.SGD","LU0321505868.SGD","LU0225284248.USD","LU1571399168.USD","IE0002141913.USD","IE0009355771.USD","LU1868836591.USD","LU1093756168.USD","LU1868836914.USD","LU2242646821.SGD","LU0868494617.USD","LU1291159041.SGD","LU1032466523.USD","LU0456855351.SGD","LU0985481810.HKD","LU1670711040.USD","BK4532","LU1093756325.SGD","LU1585245621.USD"],"gpt_icon":0},{"id":"2527446461","title":"Bristol-Myers' Camzyos Phase 3 Trial Misses Dual Primary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2527446461","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527446461?lang=en_us&edition=fundamental","pubTime":"2025-04-15 04:48","pubTimestamp":1744663733,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb  said Monday that its phase 3 Odyssey-HCM trial, which evaluated Camzyos in adults with symptomatic New York Heart Association class II-III non-obstructive hypertrophic cardiomyopathy, did not meet its dual primary endpoints.The trial failed to show a statistically significant difference from placebo in changes from baseline to week 48 in both the Kansas City Cardiomyopathy Questionnaire - Clinical Summary Score and peak oxygen consumption.No new safety signals were observed, the company added.Shares of Bristol-Myers Squibb were down 2% in after-hours trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","LU2125154778.USD","LU1093756325.SGD","LU2133065610.SGD","LU1430594728.SGD","IE00B2B36J28.USD","LU0237698245.USD","LU0456855351.SGD","LU0868494617.USD","LU1868836757.USD","MYE","IE00BSNM7G36.USD","LU1868837300.USD","IE00BFTCPJ56.SGD","LU1989771016.USD","LU1718418525.SGD","LU1868836591.USD","BK4581","IE0009355771.USD","LU2125154935.USD","LU1571399168.USD","LU0882574055.USD","LU1585245621.USD","BK4585","BK4126","LU0114720955.EUR","LU1868837136.USD","IE00BJJMRZ35.SGD","BK4007","BK4559","LU0096364046.USD","LU1261432733.SGD","LU0225771236.USD","LU1868836914.USD","LU2242652126.USD","LU0321505439.SGD","BK4534","BK4588","LU1032466523.USD","LU1670710588.SGD","LU0306806265.USD","LU2242646821.SGD","LU2360032135.SGD","LU0306807586.USD","IE0002141913.USD","BMY","LU0985481810.HKD","IE00BFXG1179.USD","LU0061475181.USD","LU1074936037.SGD"],"gpt_icon":0},{"id":"2527144898","title":"CORRECTED-UPDATE 2-Bristol Myers' heart disease drug fails to meet main goals in late-stage study (April 14)","url":"https://stock-news.laohu8.com/highlight/detail?id=2527144898","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527144898?lang=en_us&edition=fundamental","pubTime":"2025-04-15 04:46","pubTimestamp":1744663564,"startTime":"0","endTime":"0","summary":"CORRECTED-UPDATE 2-Bristol Myers' heart disease drug fails to meet main goals in late-stage study In April 14 story, corrects headquarters in paragraph 2 to \"New Jersey\" from \"New York\", removes extraneous words in paragraph 3","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nL4N3QS1J6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306807586.USD","LU1323610961.USD","LU1093756168.USD","IE00BSNM7G36.USD","LU1261432733.SGD","LU1032466523.USD","LU0096364046.USD","LU1670710661.SGD","LU1670711123.USD","LU1430594728.SGD","LU0237698245.USD","LU1074936037.SGD","LU1868837300.USD","LU0114720955.EUR","BK4559","LU0061475181.USD","BK4532","LU0985481810.HKD","LU0225771236.USD","LU1093756325.SGD","LU2242646821.SGD","IE00BFTCPJ56.SGD","BK4581","LU0882574055.USD","IE0002141913.USD","LU2125154778.USD","BK4585","LU1868836757.USD","LU0225284248.USD","BK4007","LU0456855351.SGD","LU1585245621.USD","BK4588","IE00BJT1NW94.SGD","LU2242652126.USD","IE00BJJMRZ35.SGD","BMY","LU1571399168.USD","LU0321505868.SGD","IE0009355771.USD","LU2133065610.SGD","LU0321505439.SGD","LU1670710588.SGD","LU1670711040.USD","LU2360032135.SGD","IE00BFXG1179.USD","LU1868836591.USD","LU1989771016.USD","LU1868836914.USD","BK4534"],"gpt_icon":0},{"id":"2527907141","title":"Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2527907141","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527907141?lang=en_us&edition=fundamental","pubTime":"2025-04-15 04:37","pubTimestamp":1744663020,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Bristol Myers Squibb Co.  advanced 1.24% to $51.34 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.79% to 5,405.97 and the Dow Jones Industrial Average  rising 0.78% to 40,524.79.This was the stock's second consecutive day of gains.Bristol Myers Squibb Co. closed 18.93% short of its 52-week high of $63.33, which the company achieved on March 11th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  rose 1.73% to $154.36, Pfizer Inc.  rose 0.96% to $22.12, and Abbott Laboratories  rose 0.85% to $127.96.Trading volume  eclipsed its 50-day average volume of 13.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 14, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently f","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","MYE"],"gpt_icon":0},{"id":"2527014190","title":"Bristol Myers says Phase 3 ODYSSEY-HCM Camzyos trial did not meet endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2527014190","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527014190?lang=en_us&edition=fundamental","pubTime":"2025-04-15 04:20","pubTimestamp":1744662011,"startTime":"0","endTime":"0","summary":"Bristol Myers (BMY) Squibb “announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos for the treatment of adult patients with symptomatic New Yor...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bristol-myers-says-phase-3-odyssey-hcm-camzyos-trial-did-not-meet-endpoints?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bristol-myers-says-phase-3-odyssey-hcm-camzyos-trial-did-not-meet-endpoints?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2125154778.USD","LU0061475181.USD","LU0225771236.USD","LU1670711040.USD","LU0985481810.HKD","LU1868837136.USD","LU2125154935.USD","LU0114720955.EUR","LU2360032135.SGD","BK4007","LU2242646821.SGD","BK4588","LU0306807586.USD","LU1074936037.SGD","IE00B2B36J28.USD","LU0321505439.SGD","LU1291159041.SGD","LU1868836757.USD","LU1718418525.SGD","BK4585","LU1430594728.SGD","LU1093756325.SGD","LU1093756168.USD","LU1670710588.SGD","LU1323610961.USD","IE00BJT1NW94.SGD","BK4559","IE00BSNM7G36.USD","IE0009355771.USD","LU1670710661.SGD","LU0096364046.USD","IE00BFTCPJ56.SGD","BK4532","LU1868837300.USD","HCM","LU2133065610.SGD","MYE","LU1032466523.USD","LU1989771016.USD","BK4534","LU2242652126.USD","BK4531","BK4581","BMY","LU1571399168.USD","LU1261432733.SGD","LU1868836914.USD","LU0225284248.USD","LU0306806265.USD","LU0237698245.USD"],"gpt_icon":0},{"id":"2527740146","title":"Bristol-Myers Squibb Co - No New Safety Signals Observed in Odyssey-HCM Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2527740146","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527740146?lang=en_us&edition=fundamental","pubTime":"2025-04-15 04:15","pubTimestamp":1744661700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nTUA2ZKXFC:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0306807586.USD","LU1323610961.USD","LU1093756168.USD","IE00BSNM7G36.USD","LU1261432733.SGD","LU1032466523.USD","LU0096364046.USD","LU1670710661.SGD","LU1670711123.USD","LU1430594728.SGD","LU0237698245.USD","LU1074936037.SGD","LU1868837300.USD","LU0114720955.EUR","BK4559","LU0061475181.USD","BK4532","LU1868837136.USD","LU0985481810.HKD","LU1093756325.SGD","IE00BFTCPJ56.SGD","BK4581","LU0882574055.USD","LU1718418525.SGD","LU2125154778.USD","BK4585","LU1868836757.USD","LU0225284248.USD","BK4007","LU0456855351.SGD","LU1585245621.USD","BK4588","IE00BJT1NW94.SGD","LU0868494617.USD","LU2242652126.USD","IE00BJJMRZ35.SGD","BMY","LU1571399168.USD","LU2125154935.USD","LU0321505868.SGD","LU2133065610.SGD","LU0321505439.SGD","LU0306806265.USD","LU1670711040.USD","LU2360032135.SGD","IE00BFXG1179.USD","LU1868836591.USD","LU1291159041.SGD","LU1989771016.USD","BK4534"],"gpt_icon":0},{"id":"2527814287","title":"Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2527814287","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527814287?lang=en_us&edition=fundamental","pubTime":"2025-04-15 04:15","pubTimestamp":1744661700,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J., April 14, 2025----Bristol Myers Squibb  today announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos  for the treatment of adult patients with symptomatic New York Heart Association  class II-III non-obstructive hypertrophic cardiomyopathy  did not meet its dual primary endpoints of changes from baseline to Week 48 compared to placebo in the Kansas City Cardiomyopathy Questionnaire – Clinical Summary Score  and peak oxygen consumption . No new safety signals were observed.\"While these results are disappointing, the ODYSSEY-HCM trial meaningfully contributes to the understanding of non-obstructive HCM, a disease where there remains a significant need for new treatment options,\" said Roland Chen, MD, senior vice president, drug development, Immunology and Cardiovascular Medicines, Bristol Myers Squibb. \"These findings represent the first Phase 3 clinical trial data for a cardiac myosin inhibitor in non-obstructive HCM. Importantly, these results do not change the fav","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bristol-myers-squibb-provides-phase-201500074.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0061475181.USD","LU0868494617.USD","IE00BFTCPJ56.SGD","LU0882574055.USD","LU2242646821.SGD","BK4126","BK4531","LU2133065610.SGD","LU1868837300.USD","LU1868836591.USD","LU0225771236.USD","MYE","LU1868836757.USD","BK4585","LU1323610961.USD","LU1989771016.USD","BK4581","IE00BSNM7G36.USD","LU2360032135.SGD","BK4588","LU1261432733.SGD","LU1571399168.USD","LU1093756168.USD","LU1430594728.SGD","LU1585245621.USD","LU1670710661.SGD","LU2125154935.USD","BK4534","LU1670711123.USD","LU1868837136.USD","BK4559","LU0321505868.SGD","LU1291159041.SGD","IE00BFXG1179.USD","BK4213","BMY","IE00B2B36J28.USD","LU2242652126.USD","SD","IE0009355771.USD","BK4007","LU1670710588.SGD","LU0306806265.USD","IE0002141913.USD","BK4532","LU0456855351.SGD","LU0237698245.USD","IE00BJJMRZ35.SGD","HCM","LU1032466523.USD"],"gpt_icon":0},{"id":"2526605919","title":"Nu, HPE, Merck, BMY, OXY: Trending by Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2526605919","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526605919?lang=en_us&edition=fundamental","pubTime":"2025-04-12 17:01","pubTimestamp":1744448471,"startTime":"0","endTime":"0","summary":"Analysts are intrested in these 5 stocks: ( ($NU) ), ( ($HPE) ), ( ($MRK) ), ( ($BMY) ) and ( ($OXY) ). Here is a breakdown of their recent","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/nu-hpe-merck-bmy-oxy-trending-by-analysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/nu-hpe-merck-bmy-oxy-trending-by-analysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0456855351.SGD","LU1066051498.USD","LU0211331839.USD","IE00BFXG1179.USD","BK4532","LU1093756325.SGD","LU1261432733.SGD","LU1989771016.USD","LU2106854487.HKD","LU1934455277.USD","IE00BLSP4452.SGD","LU1989772923.USD","BK4585","IE0002141913.USD","LU1868836591.USD","LU1670710661.SGD","LU1941712264.USD","LU1066051811.HKD","LU2468319806.SGD","OXY","LU2125154935.USD","LU0306806265.USD","LU0348723411.USD","LU2242646821.SGD","LU1291159041.SGD","MRK","LU0070302665.USD","SG9999014575.USD","LU0320765489.SGD","LU0868494617.USD","IE00BLSP4239.USD","BMY","IE0009355771.USD","LU0321505439.SGD","LU0234572021.USD","LU1571399168.USD","SG9999002224.SGD","LU0882574055.USD","LU0114720955.EUR","IE00BSNM7G36.USD","LU0289739699.SGD","LU1023059063.AUD","LU0965509283.SGD","HPE","LU2023250504.SGD","LU0266013472.USD","LU0321505868.SGD","SG9999015341.SGD","IE00BJJMRZ35.SGD","LU0058720904.USD"],"gpt_icon":0},{"id":"2526494576","title":"Bristol-Myers Squibb Gets FDA Approval for Opdivo-Yervoy Combo in Liver Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2526494576","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526494576?lang=en_us&edition=fundamental","pubTime":"2025-04-12 04:46","pubTimestamp":1744404398,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb  received the US Food and Drug Administration's full approval for Opdivo plus Yervoy as a first-line treatment for adults with unresectable or metastatic hepatocellular carcinoma, a form of liver cancer.The approval was supported by results from a phase 3 trial, which demonstrated that the combination therapy significantly improved overall survival to 23.7 months, compared with 20.6 months with lenvatinib or sorafenib, reducing the risk of death by 21%, the company said Friday in a statement.The trial's safety analysis involved 657 patients with 332 receiving Opdivo plus Yervoy, and 53% of those patients experienced serious adverse reactions, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","LU1323610961.USD","LU2125154778.USD","LU2133065610.SGD","LU1430594728.SGD","IE00B2B36J28.USD","LU0456855351.SGD","LU1868836757.USD","LU0868494617.USD","LU1670710661.SGD","IE00BSNM7G36.USD","LU1868837300.USD","LU1291159041.SGD","LU1989771016.USD","LU1670711123.USD","LU1718418525.SGD","LU1868836591.USD","BK4581","IE0009355771.USD","LU2125154935.USD","LU1571399168.USD","BK4585","LU0321505868.SGD","LU0114720955.EUR","IE00BJJMRZ35.SGD","BK4007","BK4559","LU0096364046.USD","LU1670711040.USD","LU1261432733.SGD","LU0225771236.USD","LU1868836914.USD","LU2242652126.USD","LU0321505439.SGD","BK4534","LU0225284248.USD","BK4588","LU1093756168.USD","LU1032466523.USD","IE00BJT1NW94.SGD","LU1670710588.SGD","LU0306806265.USD","LU2242646821.SGD","LU2360032135.SGD","LU0306807586.USD","IE0002141913.USD","BMY","LU0985481810.HKD","IE00BFXG1179.USD","LU0061475181.USD"],"gpt_icon":0},{"id":"2526646177","title":"FDA Approves Bristol Myers Squibb's Opdivo Plus Yervoy to Treat Some Carcinomas","url":"https://stock-news.laohu8.com/highlight/detail?id=2526646177","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526646177?lang=en_us&edition=fundamental","pubTime":"2025-04-12 04:33","pubTimestamp":1744403580,"startTime":"0","endTime":"0","summary":"Bristol Myers Squibb said the Food and Drug Administration approved Opdivo plus Yervoy as a first-line treatment for certain types of carcinoma.Opdivo, or nivolumab, plus Yervoy, or ipilimumab, was approved as a first-line treatment for adult patients with unresectable or metastatic hepatocellular carcinoma, the company said Friday. HCC is the most common primary liver cancer, according to the company.The company also said Phase 3 trial results showed Opdivo plus Yervoy demonstrated a statistically significant overall survival benefit compared to the investigator's choice of lenvatinib or sorafenib.The combination treatment received accelerated approval from the FDA in 2020 and has been an established second-line treatment for patients with advanced HCC who were previously treated with sorafenib.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","IE00BFTCPJ56.SGD","LU1323610961.USD","IE00B2B36J28.USD","IE0002141913.USD","LU1571399168.USD","BK4559","LU0306806265.USD","BMY","LU0321505868.SGD","LU1261432733.SGD","LU0868494617.USD","LU2125154778.USD","LU2360032135.SGD","LU1989771016.USD","LU1291159041.SGD","LU0882574055.USD","LU1670710661.SGD","LU1868836591.USD","BK4007","LU1868836914.USD","IE00BFXG1179.USD","LU0321505439.SGD","LU1868836757.USD","LU1868837136.USD","BK4532","LU1718418525.SGD","LU0456855351.SGD","LU0225771236.USD","LU1074936037.SGD","IE00BJJMRZ35.SGD","LU1430594728.SGD","LU1670710588.SGD","LU2242646821.SGD","LU1032466523.USD","LU2125154935.USD","LU1585245621.USD","LU1670711123.USD","IE00BJT1NW94.SGD","LU0985481810.HKD","MYE","LU0114720955.EUR","LU0061475181.USD","LU1093756168.USD","LU0306807586.USD","BK4126","LU1093756325.SGD","LU0237698245.USD","BK4581","LU1670711040.USD"],"gpt_icon":0},{"id":"2526643131","title":"Bristol Myers says FDA approves Opdivo plus Yervoy as first-line HCC treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2526643131","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526643131?lang=en_us&edition=fundamental","pubTime":"2025-04-12 03:55","pubTimestamp":1744401321,"startTime":"0","endTime":"0","summary":"Bristol Myers (BMY) Squibb announced that the U.S. Food and Drug Administration approved Opdivo plus Yervoy as a first-line treatment for adult pat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bristol-myers-says-fda-approves-opdivo-plus-yervoy-as-first-line-hcc-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bristol-myers-says-fda-approves-opdivo-plus-yervoy-as-first-line-hcc-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","LU1430594728.SGD","IE00BJT1NW94.SGD","LU0882574055.USD","LU1868836914.USD","LU2242646821.SGD","LU1571399168.USD","LU1670710588.SGD","IE00BSNM7G36.USD","LU0061475181.USD","LU2125154935.USD","BK4581","LU0321505868.SGD","BK4585","LU0868494617.USD","BK4559","LU1261432733.SGD","LU1868836591.USD","BK4588","LU0225284248.USD","LU1718418525.SGD","LU1323610961.USD","LU1093756325.SGD","LU1074936037.SGD","LU2133065610.SGD","LU1868836757.USD","BK4534","BK4006","LU0237698245.USD","IE00BJJMRZ35.SGD","LU1670710661.SGD","LU2360032135.SGD","LU1291159041.SGD","LU1868837136.USD","LU0114720955.EUR","LU0306807586.USD","LU0306806265.USD","IE00B2B36J28.USD","LU0985481810.HKD","LU0225771236.USD","LU1868837300.USD","LU1032466523.USD","BK4007","LU1670711040.USD","MYE","HCC","BMY","LU1670711123.USD","LU0321505439.SGD","BK4532"],"gpt_icon":0},{"id":"2526761747","title":"Bristol-Myers Squibb Investors Likely to Focus on Performance of New Schizophrenia Therapy, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2526761747","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526761747?lang=en_us&edition=fundamental","pubTime":"2025-04-12 03:12","pubTimestamp":1744398775,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb (BMY) investors will be focused on the trajectory of Cobenfy, its schizophrenia therapy, on its first full quarter on the market, UBS said in a note emailed Friday.The brokerage b","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","IE00BJJMRZ35.SGD","BK4585","LU2360032135.SGD","LU2242646821.SGD","IE0009355771.USD","LU2125154778.USD","LU1868836591.USD","LU0096364046.USD","LU0882574055.USD","LU1074936037.SGD","LU1670710661.SGD","LU1989771016.USD","LU0985481810.HKD","LU1323610961.USD","LU1868836914.USD","IE00BJT1NW94.SGD","LU0456855351.SGD","LU1093756325.SGD","LU1670710588.SGD","BK4559","LU1868837136.USD","BK4532","LU1291159041.SGD","LU1571399168.USD","LU1670711040.USD","BK4211","BK4534","LU2242652126.USD","LU0225771236.USD","LU0114720955.EUR","LU1868836757.USD","BMY","LU2125154935.USD","BK4581","LU1670711123.USD","IE00BSNM7G36.USD","LU1718418525.SGD","LU1430594728.SGD","LU0306807586.USD","LU0321505868.SGD","BK4007","LU0321505439.SGD","LU0868494617.USD","IE0002141913.USD","ISBC","IE00BFTCPJ56.SGD","LU2133065610.SGD","LU0061475181.USD","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2526561561","title":"Pharma Tariffs Are Coming. Investors Underestimate the Risk. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2526561561","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526561561?lang=en_us&edition=fundamental","pubTime":"2025-04-12 01:13","pubTimestamp":1744391580,"startTime":"0","endTime":"0","summary":"While President Donald Trump and his advisers have waffled on the fate of their so-called reciprocal tariff plan, they have remained rock solid on another trade promise: big tariffs for drugmakers.Trump vowed late Tuesday he would soon impose \"a major tariff on pharmaceuticals,\" and on Wednesday, after Trump suspended the \"reciprocal\" tariffs on most trading partners, Treasury Secretary Scott Bessent said during a news conference the pharmaceutical tariffs were still coming.Later that day, talking to reporters in the Oval Office, Trump suggested the tariffs on pharmaceuticals could be as high as 200%.Since the market opened the day after Trump's initial \"reciprocal\" tariff announcement on April 2, AbbVie shares have fallen the most of the big biopharma names. AbbVie was down 15.3% as of midmorning Friday, while the NYSE Arca Pharmaceutical Index was down 9.6%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ","SG9999002232.USD","SG9999014898.SGD","LU2089984988.USD","LU2264538146.SGD","LU2471134796.USD","BIIB","LU2471134879.HKD","LU1366192091.USD","LU0882574139.USD","LU1074936037.SGD","LU2360106947.USD","PFE","LU1291159041.SGD","LU1196500208.SGD","LU1066051225.USD","LU0058720904.USD","LU1674673428.USD","LU0079474960.USD","VERX","ISBC","IE00B42XCP33.USD","LU1093756168.USD","BK4023","SG9999013999.USD","LU2237443978.SGD","SG9999015986.USD","LU1221951129.SGD","LU2592432038.USD","LU1670710661.SGD","VRTX","LU2265009873.SGD","LU0889565916.HKD","LU0122379950.USD","BK4588","BMY","LU0237698245.USD","LU2491050154.USD","BK4592","LU2750360997.AUD","LU0098860793.USD","LU0385154629.USD","LU2237443465.HKD","IE00B2B36J28.USD","LU2430703251.USD","LU0238689110.USD","LU1670711040.USD","LU1894683348.USD","LU0640476718.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMY\",params:#limit:5,,,undefined,":[{"date":"2025-04-24","symbol":"BMY","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":1.54,"defaultRemindTime":1745481600000,"name":null,"time":"Pre-Market","dateTimestamp":1745467200000,"actualEps":null},{"date":"2025-04-04","symbol":"BMY","amount":0.62,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-04","defaultRemindTime":1743773400000,"name":"施贵宝","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-01","payableDate":"2025-04-04","currency":"USD","dateTimestamp":1743739200000,"payDate":"2025-05-01"},{"market":"US","date":"2025-02-06","symbol":"BMY","fiscalQuarterEnding":"2024/12","expectedEps":1.46,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738818000000,"reportTimeType":"pre","actualEps":1.67},{"date":"2025-01-03","symbol":"BMY","amount":0.62,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-01-03","defaultRemindTime":1735914600000,"name":"施贵宝","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-03","payableDate":"2025-01-03","currency":"USD","dateTimestamp":1735880400000,"payDate":"2025-02-03"},{"market":"US","date":"2024-10-31","symbol":"BMY","fiscalQuarterEnding":"2024/09","expectedEps":1.49,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"pre","actualEps":1.8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMY\",market:\"US\",,,undefined,":[{"executeDate":"2015-07-01","recordDate":"2015-07-06","paymentDate":"2015-08-03","value":0.37,"currency":"USD"},{"executeDate":"2015-09-30","recordDate":"2015-10-02","paymentDate":"2015-11-02","value":0.37,"currency":"USD"},{"executeDate":"2015-12-30","recordDate":"2016-01-04","paymentDate":"2016-02-01","value":0.38,"currency":"USD"},{"executeDate":"2016-03-30","recordDate":"2016-04-01","paymentDate":"2016-05-02","value":0.38,"currency":"USD"},{"executeDate":"2016-06-29","recordDate":"2016-07-01","paymentDate":"2016-08-01","value":0.38,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1429,"buy":0.1071,"hold":0.6786,"sell":0.0714,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6786,"analysts":28,"updateTime":1745294400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BMY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BMY","date":"2025-04-22","current":-11.12889,"percent":0.493095,"low":-3427.632189,"twenty":-24.204041,"median":12.10488,"eighty":23.409797,"high":152.008162,"avg":-163.317688,"sd":702.176262,"marketCap":99581310812},"quantilePoints":[{"date":"2020-04-24","current":40.953284,"twenty":26.163897,"median":40.595255,"eighty":57.731222,"marketCap":140838343724},{"date":"2020-05-01","current":39.644095,"twenty":26.163897,"median":40.646079,"eighty":57.731222,"marketCap":136336041651},{"date":"2020-05-08","current":144.797914,"twenty":26.163897,"median":40.716632,"eighty":57.780539,"marketCap":138137209542},{"date":"2020-05-15","current":152.008162,"twenty":26.163897,"median":40.828913,"eighty":58.028862,"marketCap":145015786397},{"date":"2020-05-22","current":144.181248,"twenty":26.163897,"median":40.989755,"eighty":58.258767,"marketCap":137548910206},{"date":"2020-05-29","current":141.64343,"twenty":26.163897,"median":41.152517,"eighty":58.434572,"marketCap":135127832168},{"date":"2020-06-05","current":145.462015,"twenty":26.163897,"median":41.507602,"eighty":58.543425,"marketCap":138770762674},{"date":"2020-06-12","current":133.223568,"twenty":26.163897,"median":41.630405,"eighty":58.70227,"marketCap":127095283538},{"date":"2020-06-19","current":133.792798,"twenty":26.163897,"median":41.779831,"eighty":59.065322,"marketCap":127638329079},{"date":"2020-06-26","current":136.472923,"twenty":26.163897,"median":41.955835,"eighty":59.303982,"marketCap":130195168502},{"date":"2020-07-02","current":140.26779,"twenty":26.163897,"median":42.192232,"eighty":59.612319,"marketCap":133815472110},{"date":"2020-07-10","current":136.212026,"twenty":26.163897,"median":42.354947,"eighty":59.954728,"marketCap":129946272629},{"date":"2020-07-17","current":143.232531,"twenty":26.163897,"median":42.505381,"eighty":60.343483,"marketCap":136643834304},{"date":"2020-07-24","current":137.208179,"twenty":26.163897,"median":42.754058,"eighty":60.719618,"marketCap":130896602326},{"date":"2020-07-31","current":139.12933,"twenty":26.163897,"median":43.2132,"eighty":60.965815,"marketCap":132729381028},{"date":"2020-08-07","current":-244.289683,"twenty":26.104809,"median":43.30835,"eighty":63.241479,"marketCap":137535091427},{"date":"2020-08-14","current":-252.857036,"twenty":25.671207,"median":43.30835,"eighty":63.241479,"marketCap":142358511546},{"date":"2020-08-21","current":-248.973703,"twenty":24.738199,"median":43.30835,"eighty":63.241479,"marketCap":140172194950},{"date":"2020-08-28","current":-249.694322,"twenty":24.53695,"median":43.30835,"eighty":63.241479,"marketCap":140577903184},{"date":"2020-09-04","current":-240.006006,"twenty":24.217273,"median":43.30835,"eighty":63.241479,"marketCap":135123381368},{"date":"2020-09-11","current":-236.162707,"twenty":23.958745,"median":43.30835,"eighty":63.241479,"marketCap":132959604118},{"date":"2020-09-18","current":-237.283669,"twenty":23.923139,"median":43.30835,"eighty":63.241479,"marketCap":133590705816},{"date":"2020-09-25","current":-238.164425,"twenty":23.703169,"median":43.30835,"eighty":63.241479,"marketCap":134086571436},{"date":"2020-10-02","current":-235.081779,"twenty":23.363915,"median":43.30835,"eighty":63.241479,"marketCap":132351041767},{"date":"2020-10-09","current":-247.492432,"twenty":17.593463,"median":43.30835,"eighty":63.241479,"marketCap":139338239135},{"date":"2020-10-16","current":-245.170439,"twenty":17.05085,"median":43.30835,"eighty":63.241479,"marketCap":138030957047},{"date":"2020-10-23","current":-240.726625,"twenty":16.915253,"median":43.30835,"eighty":63.241479,"marketCap":135529089602},{"date":"2020-10-30","current":-234.000852,"twenty":16.878905,"median":43.30835,"eighty":63.241479,"marketCap":131742479415},{"date":"2020-11-06","current":-3276.639701,"twenty":16.797113,"median":43.30835,"eighty":63.241479,"marketCap":144172146848},{"date":"2020-11-13","current":-3267.395263,"twenty":16.644024,"median":43.30835,"eighty":63.241479,"marketCap":143765391575},{"date":"2020-11-20","current":-3164.165705,"twenty":16.603263,"median":43.30835,"eighty":63.241479,"marketCap":139223291023},{"date":"2020-11-27","current":-3238.121209,"twenty":16.551974,"median":43.30835,"eighty":63.241479,"marketCap":142477333209},{"date":"2020-12-04","current":-3200.116297,"twenty":16.449584,"median":43.30835,"eighty":63.241479,"marketCap":140805117086},{"date":"2020-12-11","current":-3118.457095,"twenty":16.271128,"median":43.30835,"eighty":63.241479,"marketCap":137212112172},{"date":"2020-12-18","current":-3241.716269,"twenty":16.177691,"median":43.24944,"eighty":63.241479,"marketCap":142635515816},{"date":"2020-12-24","current":-3140.54103,"twenty":15.969441,"median":43.24944,"eighty":63.241479,"marketCap":138183805325},{"date":"2020-12-31","current":-3185.73606,"twenty":15.745139,"median":43.24944,"eighty":63.241479,"marketCap":140172386661},{"date":"2021-01-08","current":-3209.360735,"twenty":15.520794,"median":43.24944,"eighty":63.241479,"marketCap":141211872359},{"date":"2021-01-15","current":-3417.360591,"twenty":15.454453,"median":43.24944,"eighty":63.241479,"marketCap":150363866007},{"date":"2021-01-22","current":-3315.671773,"twenty":15.292279,"median":43.24944,"eighty":63.241479,"marketCap":145889558002},{"date":"2021-01-29","current":-3154.921267,"twenty":15.193414,"median":43.24944,"eighty":63.241479,"marketCap":138816535750},{"date":"2021-02-05","current":-15.270556,"twenty":15.111639,"median":43.24944,"eighty":63.241479,"marketCap":137664062476},{"date":"2021-02-12","current":-14.909163,"twenty":15.037512,"median":43.24944,"eighty":63.241479,"marketCap":134406104428},{"date":"2021-02-19","current":-15.060765,"twenty":14.994264,"median":43.24944,"eighty":63.241479,"marketCap":135772794271},{"date":"2021-02-26","current":-15.24219,"twenty":14.895142,"median":43.24944,"eighty":63.241479,"marketCap":137408341133},{"date":"2021-03-05","current":-15.018515,"twenty":14.827729,"median":43.252713,"eighty":64.853776,"marketCap":135391913495},{"date":"2021-03-12","current":-15.070706,"twenty":14.750073,"median":43.252713,"eighty":64.853776,"marketCap":135862413277},{"date":"2021-03-19","current":-15.582672,"twenty":14.671279,"median":43.252713,"eighty":64.853776,"marketCap":140477792093},{"date":"2021-03-26","current":-15.84441,"twenty":14.611498,"median":43.24944,"eighty":63.241479,"marketCap":142837352227},{"date":"2021-04-01","current":-15.59413,"twenty":14.591649,"median":43.24944,"eighty":63.241479,"marketCap":140581085012},{"date":"2021-04-09","current":-15.514834,"twenty":14.520487,"median":43.252713,"eighty":64.853776,"marketCap":139866228072},{"date":"2021-04-16","current":-16.221067,"twenty":14.424522,"median":43.252713,"eighty":64.853776,"marketCap":146232922690},{"date":"2021-04-23","current":-16.357358,"twenty":14.234366,"median":43.246167,"eighty":64.853776,"marketCap":147461583055},{"date":"2021-04-30","current":-22.411016,"twenty":14.031315,"median":41.99272,"eighty":64.853776,"marketCap":139374107187},{"date":"2021-05-07","current":-23.136268,"twenty":13.765653,"median":40.725784,"eighty":64.853776,"marketCap":143884451572},{"date":"2021-05-14","current":-23.294244,"twenty":13.598846,"median":40.216454,"eighty":64.853776,"marketCap":144866902824},{"date":"2021-05-21","current":-24.073352,"twenty":13.387812,"median":39.861196,"eighty":64.853776,"marketCap":149712173772},{"date":"2021-05-28","current":-23.595834,"twenty":13.305536,"median":39.584885,"eighty":64.853776,"marketCap":146742491578},{"date":"2021-06-04","current":-23.315786,"twenty":13.183703,"median":39.110931,"eighty":64.853776,"marketCap":145000873449},{"date":"2021-06-11","current":-24.177472,"twenty":13.076111,"median":38.321748,"eighty":64.853776,"marketCap":150359698461},{"date":"2021-06-18","current":-23.865111,"twenty":12.918943,"median":37.341182,"eighty":64.853776,"marketCap":148417124394},{"date":"2021-06-25","current":-23.962051,"twenty":12.713253,"median":37.032625,"eighty":64.853776,"marketCap":149019992208},{"date":"2021-07-02","current":-24.037448,"twenty":12.656819,"median":36.735495,"eighty":64.853776,"marketCap":149488889397},{"date":"2021-07-09","current":-24.112846,"twenty":12.542371,"median":36.569788,"eighty":64.853776,"marketCap":149957786585},{"date":"2021-07-16","current":-24.163111,"twenty":12.276028,"median":36.398367,"eighty":64.853776,"marketCap":150270384711},{"date":"2021-07-23","current":-24.536508,"twenty":12.058207,"median":36.20409,"eighty":64.853776,"marketCap":152592542216},{"date":"2021-07-30","current":-29.693807,"twenty":11.96591,"median":36.009813,"eighty":61.057,"marketCap":150814846842},{"date":"2021-08-06","current":-29.803185,"twenty":-14.753585,"median":35.906961,"eighty":60.876911,"marketCap":151370375230},{"date":"2021-08-13","current":-29.536304,"twenty":-14.987324,"median":35.781252,"eighty":60.876911,"marketCap":150014885963},{"date":"2021-08-20","current":-30.275696,"twenty":-15.059273,"median":34.627419,"eighty":60.876911,"marketCap":153770257867},{"date":"2021-08-27","current":-29.138169,"twenty":-15.115938,"median":34.17561,"eighty":60.876911,"marketCap":147992762629},{"date":"2021-09-03","current":-28.705034,"twenty":-15.248154,"median":33.35279,"eighty":60.876911,"marketCap":145792870212},{"date":"2021-09-10","current":-27.62001,"twenty":-15.348311,"median":32.979745,"eighty":60.876911,"marketCap":140282028600},{"date":"2021-09-17","current":-26.823741,"twenty":-15.441509,"median":32.518541,"eighty":60.876911,"marketCap":136237781934},{"date":"2021-09-24","current":-26.35123,"twenty":-15.542928,"median":32.364263,"eighty":60.876911,"marketCap":133837899297},{"date":"2021-10-01","current":-26.036223,"twenty":-15.613954,"median":32.061419,"eighty":60.876911,"marketCap":132237977539},{"date":"2021-10-08","current":-25.051826,"twenty":-15.777999,"median":31.581441,"eighty":60.876911,"marketCap":127238222044},{"date":"2021-10-15","current":-25.533087,"twenty":-16.234944,"median":30.750116,"eighty":60.876911,"marketCap":129682546953},{"date":"2021-10-22","current":-25.200579,"twenty":-16.36727,"median":30.429194,"eighty":60.876911,"marketCap":127993740652},{"date":"2021-10-29","current":-23.982843,"twenty":-22.664495,"median":30.34167,"eighty":60.876911,"marketCap":129627264204},{"date":"2021-11-05","current":-24.414041,"twenty":-23.13914,"median":30.156897,"eighty":60.876911,"marketCap":131957891385},{"date":"2021-11-12","current":-24.405828,"twenty":-23.227463,"median":30.035336,"eighty":60.876911,"marketCap":131913498487},{"date":"2021-11-19","current":-23.748763,"twenty":-23.330148,"median":29.933224,"eighty":60.876911,"marketCap":128362066591},{"date":"2021-11-26","current":-23.214899,"twenty":-23.393674,"median":29.797076,"eighty":60.876911,"marketCap":125476528175},{"date":"2021-12-03","current":-23.128659,"twenty":-23.393674,"median":29.729002,"eighty":60.876911,"marketCap":125010402739},{"date":"2021-12-10","current":-23.145086,"twenty":-23.461298,"median":29.636615,"eighty":60.876911,"marketCap":125099188536},{"date":"2021-12-17","current":-25.280544,"twenty":-23.568548,"median":27.951968,"eighty":60.876911,"marketCap":136641342198},{"date":"2021-12-23","current":-25.48177,"twenty":-23.634806,"median":27.65765,"eighty":60.876911,"marketCap":137728968216},{"date":"2021-12-31","current":-25.60497,"twenty":-23.766579,"median":27.039995,"eighty":60.876911,"marketCap":138394861697},{"date":"2022-01-07","current":-25.802089,"twenty":-23.903887,"median":26.592299,"eighty":60.865513,"marketCap":139460291266},{"date":"2022-01-14","current":-26.664486,"twenty":-23.969949,"median":26.503175,"eighty":60.865513,"marketCap":144121545629},{"date":"2022-01-21","current":-26.093661,"twenty":-24.000827,"median":26.434777,"eighty":60.865513,"marketCap":141036239169},{"date":"2022-01-28","current":-26.656272,"twenty":-24.081403,"median":26.28969,"eighty":60.865513,"marketCap":144077152730},{"date":"2022-02-04","current":20.625497,"twenty":-24.122181,"median":26.107856,"eighty":60.865513,"marketCap":144254724325},{"date":"2022-02-11","current":20.843465,"twenty":-24.122181,"median":25.804687,"eighty":60.865513,"marketCap":145779193401},{"date":"2022-02-18","current":21.052274,"twenty":-24.122181,"median":24.80247,"eighty":60.865513,"marketCap":147239600991},{"date":"2022-02-25","current":21.441842,"twenty":-24.122181,"median":24.575651,"eighty":60.865513,"marketCap":149964242016},{"date":"2022-03-04","current":21.616368,"twenty":-24.122181,"median":24.306674,"eighty":60.865513,"marketCap":151184881195},{"date":"2022-03-11","current":21.463658,"twenty":-24.122181,"median":23.979644,"eighty":60.865513,"marketCap":150116821913},{"date":"2022-03-18","current":22.133715,"twenty":-24.122181,"median":23.933202,"eighty":60.865513,"marketCap":154803204476},{"date":"2022-03-25","current":22.26692,"twenty":-24.122181,"median":23.737758,"eighty":60.865513,"marketCap":155734841105},{"date":"2022-04-01","current":22.431005,"twenty":-24.122181,"median":23.392104,"eighty":60.865513,"marketCap":156882450469},{"date":"2022-04-08","current":23.631255,"twenty":-24.122181,"median":23.0415,"eighty":60.865513,"marketCap":165277000447},{"date":"2022-04-14","current":23.552252,"twenty":-24.122181,"median":23.0415,"eighty":60.865513,"marketCap":164724447790},{"date":"2022-04-22","current":23.017457,"twenty":-24.122181,"median":22.955165,"eighty":60.865513,"marketCap":160984091344},{"date":"2022-04-29","current":25.636645,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":160254667678},{"date":"2022-05-06","current":26.113479,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":163235357657},{"date":"2022-05-13","current":25.817161,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":161383071741},{"date":"2022-05-20","current":25.949993,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":162213406807},{"date":"2022-05-27","current":25.932963,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":162106953593},{"date":"2022-06-03","current":25.602585,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":160041761251},{"date":"2022-06-10","current":25.575338,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":159871436109},{"date":"2022-06-17","current":25.125751,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":157061071271},{"date":"2022-06-24","current":26.893443,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":168110914838},{"date":"2022-07-01","current":26.17138,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":163597298583},{"date":"2022-07-08","current":25.674111,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":160488864747},{"date":"2022-07-15","current":25.766071,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":161063712101},{"date":"2022-07-22","current":24.846463,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":155315238569},{"date":"2022-07-29","current":23.80824,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":157539125557},{"date":"2022-08-05","current":23.272571,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":153994601994},{"date":"2022-08-12","current":24.385859,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":161361232290},{"date":"2022-08-19","current":24.308413,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":160848771052},{"date":"2022-08-26","current":22.972467,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":152008814698},{"date":"2022-09-02","current":22.139921,"twenty":-24.131516,"median":22.294813,"eighty":60.876911,"marketCap":146499856390},{"date":"2022-09-09","current":22.640094,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":149809501885},{"date":"2022-09-16","current":23.078956,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":152713448900},{"date":"2022-09-23","current":22.817575,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":150983892222},{"date":"2022-09-30","current":22.940198,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":151795289182},{"date":"2022-10-07","current":22.491656,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":148827284512},{"date":"2022-10-14","current":22.788532,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":150791719257},{"date":"2022-10-21","current":23.301613,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":154186774959},{"date":"2022-10-28","current":25.54071,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":170535320356},{"date":"2022-11-04","current":26.188951,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":174863627979},{"date":"2022-11-11","current":25.251495,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":168604229262},{"date":"2022-11-18","current":25.746817,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":171911500215},{"date":"2022-11-25","current":26.34187,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":175884664649},{"date":"2022-12-02","current":26.970165,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":180079793576},{"date":"2022-12-09","current":26.205573,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":174974610226},{"date":"2022-12-16","current":24.430389,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":163121706273},{"date":"2022-12-23","current":24.23093,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":161789919312},{"date":"2022-12-30","current":23.918444,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":159703453073},{"date":"2023-01-06","current":24.267497,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":162034080255},{"date":"2023-01-13","current":24.104606,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":160946454236},{"date":"2023-01-20","current":24.649794,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":164586671930},{"date":"2023-01-27","current":24.08466,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":160813275540},{"date":"2023-02-03","current":26.118629,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":165252565410},{"date":"2023-02-10","current":25.329282,"twenty":-24.131516,"median":22.245911,"eighty":60.555486,"marketCap":160258364307},{"date":"2023-02-17","current":23.588424,"twenty":-24.131516,"median":22.245911,"eighty":60.138319,"marketCap":149243959795},{"date":"2023-02-24","current":23.279927,"twenty":-24.131516,"median":22.245911,"eighty":59.828291,"marketCap":147292098136},{"date":"2023-03-03","current":22.988016,"twenty":-24.131516,"median":22.245911,"eighty":59.303982,"marketCap":145445175275},{"date":"2023-03-10","current":21.79715,"twenty":-24.131516,"median":22.190955,"eighty":58.624659,"marketCap":137910569514},{"date":"2023-03-17","current":22.069158,"twenty":-24.131516,"median":22.143065,"eighty":57.674063,"marketCap":139631565816},{"date":"2023-03-24","current":22.499062,"twenty":-24.131516,"median":22.143065,"eighty":57.089646,"marketCap":142351566870},{"date":"2023-03-31","current":23.040928,"twenty":-24.122181,"median":22.147947,"eighty":56.818785,"marketCap":145779951237},{"date":"2023-04-06","current":23.210469,"twenty":-24.122181,"median":22.147947,"eighty":56.570827,"marketCap":146852635917},{"date":"2023-04-14","current":23.499685,"twenty":-24.131516,"median":22.143065,"eighty":54.708084,"marketCap":148682509782},{"date":"2023-04-21","current":23.114063,"twenty":-24.131516,"median":22.143065,"eighty":52.238402,"marketCap":146242677962},{"date":"2023-04-28","current":19.428023,"twenty":-24.131516,"median":22.133715,"eighty":43.587843,"marketCap":142038275000},{"date":"2023-05-05","current":19.201013,"twenty":-24.131516,"median":22.049255,"eighty":42.979111,"marketCap":140378605761},{"date":"2023-05-12","current":19.850434,"twenty":-24.131516,"median":21.75269,"eighty":40.909864,"marketCap":145126520293},{"date":"2023-05-19","current":18.879176,"twenty":-24.131516,"median":21.57897,"eighty":40.438819,"marketCap":138025656966},{"date":"2023-05-26","current":18.551592,"twenty":-24.131516,"median":21.441842,"eighty":40.037509,"marketCap":135630691229},{"date":"2023-06-02","current":18.586075,"twenty":-24.131516,"median":21.323413,"eighty":39.672401,"marketCap":135882792885},{"date":"2023-06-09","current":18.767108,"twenty":-24.131516,"median":21.067856,"eighty":39.30989,"marketCap":137206326582},{"date":"2023-06-16","current":18.583201,"twenty":-24.131516,"median":20.924495,"eighty":38.76535,"marketCap":135861784414},{"date":"2023-06-23","current":18.764234,"twenty":-24.14085,"median":20.774901,"eighty":37.956903,"marketCap":137185318111},{"date":"2023-06-30","current":18.390674,"twenty":-24.150185,"median":19.657906,"eighty":36.490198,"marketCap":134454216832},{"date":"2023-07-07","current":18.229755,"twenty":-24.150185,"median":19.568826,"eighty":35.727263,"marketCap":133277742434},{"date":"2023-07-14","current":17.896425,"twenty":-24.150185,"median":19.258484,"eighty":33.43663,"marketCap":130840759754},{"date":"2023-07-21","current":18.324582,"twenty":-24.15952,"median":19.11768,"eighty":31.771888,"marketCap":133971021990},{"date":"2023-07-28","current":15.932591,"twenty":-24.15952,"median":18.915095,"eighty":27.682522,"marketCap":126871220392},{"date":"2023-08-04","current":16.063766,"twenty":-24.15952,"median":18.814521,"eighty":27.240851,"marketCap":127915771852},{"date":"2023-08-11","current":16.079507,"twenty":-24.15952,"median":18.65504,"eighty":26.887057,"marketCap":128041118028},{"date":"2023-08-18","current":16.30513,"twenty":-24.15952,"median":18.600443,"eighty":26.661838,"marketCap":129837746540},{"date":"2023-08-25","current":16.076884,"twenty":-24.15952,"median":18.534351,"eighty":26.588154,"marketCap":128020226998},{"date":"2023-09-01","current":16.173954,"twenty":-24.15952,"median":18.403605,"eighty":26.567923,"marketCap":128793195079},{"date":"2023-09-08","current":15.733204,"twenty":-24.15952,"median":18.315962,"eighty":26.505248,"marketCap":125283502172},{"date":"2023-09-15","current":15.607275,"twenty":-24.15952,"median":17.92516,"eighty":26.451358,"marketCap":124280732770},{"date":"2023-09-22","current":15.499711,"twenty":-24.15952,"median":17.785793,"eighty":26.356016,"marketCap":123424200572},{"date":"2023-09-29","current":15.253101,"twenty":-24.15952,"median":17.14351,"eighty":26.308627,"marketCap":121460443826},{"date":"2023-10-06","current":14.801857,"twenty":-24.15952,"median":16.994886,"eighty":26.256528,"marketCap":117867186802},{"date":"2023-10-13","current":14.759881,"twenty":-24.15952,"median":16.912197,"eighty":26.215546,"marketCap":117532930335},{"date":"2023-10-20","current":14.817598,"twenty":-24.15952,"median":16.861517,"eighty":26.181912,"marketCap":117992532978},{"date":"2023-10-27","current":13.009187,"twenty":-24.15952,"median":16.75383,"eighty":26.13539,"marketCap":107781117593},{"date":"2023-11-03","current":12.557292,"twenty":-24.15952,"median":16.645066,"eighty":26.102322,"marketCap":104037163348},{"date":"2023-11-10","current":12.380463,"twenty":-24.15952,"median":16.606678,"eighty":26.050188,"marketCap":102572137774},{"date":"2023-11-17","current":12.486069,"twenty":-24.15952,"median":16.545514,"eighty":25.981328,"marketCap":103447083603},{"date":"2023-11-24","current":12.220826,"twenty":-24.15952,"median":16.468598,"eighty":25.948631,"marketCap":101249545241},{"date":"2023-12-01","current":12.1275,"twenty":-24.15952,"median":16.323182,"eighty":25.871656,"marketCap":100476337299},{"date":"2023-12-08","current":12.319064,"twenty":-24.15952,"median":16.284141,"eighty":25.822267,"marketCap":102063448338},{"date":"2023-12-15","current":12.640794,"twenty":-24.15952,"median":16.244457,"eighty":25.741743,"marketCap":104728980980},{"date":"2023-12-22","current":12.589219,"twenty":-24.15952,"median":16.206012,"eighty":25.671391,"marketCap":104301681854},{"date":"2023-12-29","current":12.579395,"twenty":-24.15952,"median":16.17133,"eighty":25.63392,"marketCap":104220291545},{"date":"2024-01-05","current":12.780784,"twenty":-24.15952,"median":16.126731,"eighty":25.574657,"marketCap":105888792893},{"date":"2024-01-12","current":12.3338,"twenty":-24.15952,"median":16.052442,"eighty":25.53878,"marketCap":102185533803},{"date":"2024-01-19","current":12.301873,"twenty":-24.15952,"median":15.981387,"eighty":25.384604,"marketCap":101921015296},{"date":"2024-01-26","current":12.183987,"twenty":-24.15952,"median":15.915318,"eighty":25.326357,"marketCap":100944331580},{"date":"2024-02-02","current":11.953127,"twenty":-24.15952,"median":15.848219,"eighty":25.326357,"marketCap":99031659303},{"date":"2024-02-09","current":12.350536,"twenty":-24.15952,"median":15.711339,"eighty":25.326357,"marketCap":99113049612},{"date":"2024-02-16","current":12.458223,"twenty":-24.15952,"median":15.581954,"eighty":25.326357,"marketCap":99977242239},{"date":"2024-02-23","current":12.934478,"twenty":-24.15952,"median":15.510205,"eighty":25.326357,"marketCap":103799187786},{"date":"2024-03-01","current":12.788326,"twenty":-24.15952,"median":15.476991,"eighty":25.323432,"marketCap":102626315608},{"date":"2024-03-08","current":13.425852,"twenty":-24.15952,"median":15.421006,"eighty":25.323432,"marketCap":107742464938},{"date":"2024-03-15","current":13.226783,"twenty":-24.15952,"median":15.29517,"eighty":25.323432,"marketCap":106144932143},{"date":"2024-03-22","current":12.999995,"twenty":-24.15952,"median":15.228111,"eighty":25.323432,"marketCap":104324958073},{"date":"2024-03-28","current":13.418293,"twenty":-24.15952,"median":15.187513,"eighty":25.323432,"marketCap":107681799135},{"date":"2024-04-05","current":12.981358,"twenty":-24.15952,"median":15.120443,"eighty":25.326357,"marketCap":104175397951},{"date":"2024-04-12","current":12.405531,"twenty":-24.15952,"median":15.050664,"eighty":25.326357,"marketCap":99554388080},{"date":"2024-04-19","current":12.198436,"twenty":-24.15952,"median":15.01354,"eighty":25.326357,"marketCap":97892445934},{"date":"2024-04-26","current":-14.73835,"twenty":-24.15952,"median":14.996944,"eighty":25.323432,"marketCap":90611374291},{"date":"2024-05-03","current":-14.408633,"twenty":-24.15952,"median":14.996944,"eighty":25.323432,"marketCap":88584274195},{"date":"2024-05-10","current":-14.751538,"twenty":-24.15952,"median":14.897686,"eighty":25.323432,"marketCap":90692458295},{"date":"2024-05-17","current":-14.543817,"twenty":-24.15952,"median":14.883186,"eighty":25.323432,"marketCap":89415385234},{"date":"2024-05-24","current":-13.696444,"twenty":-24.15952,"median":14.851704,"eighty":25.323432,"marketCap":84205737987},{"date":"2024-05-31","current":-13.271109,"twenty":-24.15952,"median":14.843629,"eighty":25.323432,"marketCap":81590778864},{"date":"2024-06-07","current":-13.478831,"twenty":-24.15952,"median":14.843629,"eighty":25.323432,"marketCap":82867851924},{"date":"2024-06-14","current":-13.676661,"twenty":-24.15952,"median":14.80891,"eighty":25.326357,"marketCap":84084111982},{"date":"2024-06-21","current":-13.531586,"twenty":-24.15952,"median":14.706868,"eighty":25.329282,"marketCap":83192187939},{"date":"2024-06-28","current":-13.686553,"twenty":-24.161675,"median":14.733375,"eighty":25.346437,"marketCap":84144924984},{"date":"2024-07-05","current":-13.208463,"twenty":-24.161675,"median":14.649759,"eighty":25.346437,"marketCap":81205629845},{"date":"2024-07-12","current":-13.435968,"twenty":-24.161675,"median":14.578971,"eighty":25.346437,"marketCap":82604328912},{"date":"2024-07-15","current":-13.34035,"twenty":-24.161675,"median":14.578971,"eighty":25.346437,"marketCap":82016469884},{"date":"2024-08-02","current":-14.930382,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":97659625724},{"date":"2024-08-09","current":-14.521245,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":94983464089},{"date":"2024-08-16","current":-15.221736,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":99565377191},{"date":"2024-08-23","current":-14.759908,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":96544558376},{"date":"2024-08-30","current":-15.410807,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":100802088250},{"date":"2024-09-06","current":-15.435603,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":100964279864},{"date":"2024-09-13","current":-14.952078,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":97801543386},{"date":"2024-09-20","current":-15.193841,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":99382911625},{"date":"2024-09-27","current":-15.534788,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":101613046321},{"date":"2024-10-04","current":-16.799391,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":109884818647},{"date":"2024-10-11","current":-16.241478,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":106235507327},{"date":"2024-10-18","current":-16.48324,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":107816875566},{"date":"2024-10-25","current":-16.402653,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":107289752819},{"date":"2024-10-31","current":-16.322065,"twenty":-24.197578,"median":14.812351,"eighty":25.39607,"marketCap":106762630073},{"date":"2024-11-08","current":-15.288171,"twenty":-24.199732,"median":13.697044,"eighty":25.3977,"marketCap":110961545834},{"date":"2024-11-15","current":-16.347249,"twenty":-24.199732,"median":13.400607,"eighty":25.3977,"marketCap":118648335429},{"date":"2024-11-22","current":-16.2718,"twenty":-24.199732,"median":13.207884,"eighty":25.3977,"marketCap":118100727727},{"date":"2024-11-29","current":-16.548446,"twenty":-24.199732,"median":13.07937,"eighty":25.3977,"marketCap":120108622634},{"date":"2024-12-06","current":-16.442259,"twenty":-24.199732,"median":13.01341,"eighty":25.3977,"marketCap":119337915498},{"date":"2024-12-13","current":-15.726892,"twenty":-24.199732,"median":12.968664,"eighty":25.320507,"marketCap":114145783212},{"date":"2024-12-20","current":-15.732481,"twenty":-24.199732,"median":12.88985,"eighty":25.094333,"marketCap":114186346746},{"date":"2024-12-27","current":-16.207529,"twenty":-24.199732,"median":12.836673,"eighty":24.91965,"marketCap":117634247092},{"date":"2025-01-03","current":-15.869407,"twenty":-24.199732,"median":12.825525,"eighty":24.830114,"marketCap":115180153316},{"date":"2025-01-10","current":-15.874995,"twenty":-24.201887,"median":12.736577,"eighty":24.700357,"marketCap":115220716849},{"date":"2025-01-17","current":-15.754836,"twenty":-24.201887,"median":12.665354,"eighty":24.382395,"marketCap":114348600880},{"date":"2025-01-24","current":-16.526091,"twenty":-24.201887,"median":12.629443,"eighty":24.315777,"marketCap":119946368500},{"date":"2025-01-31","current":-16.526091,"twenty":-24.201887,"median":12.589219,"eighty":24.176109,"marketCap":119946368500},{"date":"2025-02-07","current":-16.045454,"twenty":-24.201887,"median":12.557292,"eighty":24.139507,"marketCap":116457904621},{"date":"2025-02-14","current":-12.693406,"twenty":-24.201887,"median":12.48999,"eighty":24.058649,"marketCap":113580593927},{"date":"2025-02-21","current":-12.652584,"twenty":-24.201887,"median":12.441862,"eighty":24.03394,"marketCap":113215317763},{"date":"2025-02-28","current":-13.33522,"twenty":-24.201887,"median":12.405023,"eighty":23.957965,"marketCap":119323546952},{"date":"2025-03-07","current":-13.648189,"twenty":-24.204041,"median":12.35322,"eighty":23.91379,"marketCap":122123997544},{"date":"2025-03-14","current":-13.670868,"twenty":-24.204041,"median":12.333293,"eighty":23.792996,"marketCap":122326928746},{"date":"2025-03-21","current":-13.702619,"twenty":-24.204041,"median":12.308013,"eighty":23.674229,"marketCap":122611032429},{"date":"2025-03-28","current":-13.357899,"twenty":-24.204041,"median":12.274857,"eighty":23.602452,"marketCap":119526478154},{"date":"2025-04-04","current":-13.14819,"twenty":-24.204041,"median":12.234334,"eighty":23.545063,"marketCap":117650007992},{"date":"2025-04-11","current":-11.474536,"twenty":-24.201887,"median":12.193385,"eighty":23.482347,"marketCap":102674150870},{"date":"2025-04-17","current":-11.224398,"twenty":-24.201887,"median":12.165443,"eighty":23.454761,"marketCap":100435911354},{"date":"2025-04-22","current":-11.12889,"twenty":-24.204041,"median":12.10488,"eighty":23.409797,"marketCap":99581310812}],"updateTime":1745411577323}}}